May 31, 07
|
| NEW STORY |
| 08:55 ET |
Targacept to Present at Bear Stearns Biotech Confab
|
 |
May 09, 07
|
| 16:05 ET |
Targacept Reports First Quarter 2007 Financial Results
|
|
Mar 22, 07
|
| 08:55 ET |
Targacept to Present at Upcoming Investor Conferences
|
|
Feb 22, 07
|
| 16:05 ET |
Targacept Reports Fourth Quarter and 2006 Financial Results
|
|
Feb 05, 07
|
| 09:00 ET |
Targacept to Present at BIO CEO and Investor Conference
|
|
Jan 08, 07
|
| 08:55 ET |
Targacept Initiates Phase I Clinical Trial of TC-2216
|
|
Dec 27, 06
|
| 08:55 ET |
Targacept to Receive $20 Million Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480 (TC-1734)
|
|
Dec 19, 06
|
| 08:55 ET |
Targacept Begins Phase II Clinical Trial in Acute Post-Operative Pain
|
|
Dec 04, 06
|
| 15:00 ET |
Targacept to Ring the NASDAQ Stock Market Closing Bell
|
|
Nov 29, 06
|
| 08:55 ET |
Targacept to Host NNR Analyst Day in New York
|
|
Nov 21, 06
|
| 08:55 ET |
Targacept to Present at Lazard and CIBC Investor Conferences
|
|
Nov 14, 06
|
| 15:07 ET |
Joey Cheek, Olympic Gold Medalist, Keynote Speaker at Triad Philanthropy Awards
|
|
Nov 09, 06
|
| 16:01 ET |
Targacept Reports Third Quarter 2006 Financial Results
|
|
| 08:55 ET |
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
|
|
Nov 02, 06
|
| 08:55 ET |
Targacept to Report Third Quarter Financial Results on November 9, 2006
|
|
Oct 25, 06
|
| 08:55 ET |
Targacept to Present at Upcoming Investor Conferences
|
|
Oct 24, 06
|
| 08:55 ET |
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
|
|
Oct 17, 06
|
| 12:00 ET |
Targacept Presents Data at the 36th Annual Meeting of the Society for Neuroscience
|
|
Aug 30, 06
|
| 09:00 ET |
Targacept to Present at Thomas Weisel Partners Healthcare Conference
|
|
Aug 09, 06
|
| 16:01 ET |
Targacept Reports Second Quarter 2006 Financial Results
|
|
Jun 06, 06
|
| 10:00 ET |
Targacept to Present at Pacific Growth Equities Life Sciences Growth Conference
|
|
May 25, 06
|
| 16:50 ET |
Targacept Reports First Quarter 2006 Financial Results
|
|
May 17, 06
|
| 09:00 ET |
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
|
|
May 16, 06
|
| 09:00 ET |
Targacept Announces Upcoming Conference Participation
|
|
Apr 12, 06
|
| 09:00 ET |
Targacept Announces Pricing of Its Initial Public Offering
|
|
Feb 06, 06
|
| 08:12 ET |
Targacept Announces Early Completion of Hart-Scott-Rodino Waiting Period for Agreement With AstraZeneca
|
|
Jan 17, 06
|
| 08:57 ET |
Targacept Files for Initial Public Offering
|
|
Dec 28, 05
|
| 02:38 ET |
Targacept and AstraZeneca Announce Global License and Research Collaboration Agreement
|
|
Nov 15, 05
|
| 09:05 ET |
Targacept Presents Data at the 35th Annual Meeting of the Society for Neuroscience
|
|
Jul 06, 05
|
| 09:03 ET |
Targacept Reports Positive Phase 2 Data on Ispronicline, a Novel Small Molecule Being Developed for Treatment of Alzheimer's Disease and Age Associated Memory Impairment
|
|
Jun 30, 05
|
| 09:18 ET |
Targacept Compounds Show Long-Lasting Improvement in Cognition, According To Trends in Pharmacological Sciences Publication
|
|
Jun 02, 05
|
| 11:05 ET |
Targacept to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference
|
|
May 03, 05
|
| 14:08 ET |
Harmony Contest Brings Great Music to Greensboro
|
|
Apr 28, 05
|
| 09:03 ET |
Targacept to Present at the Deutsche Bank 30th Annual Health Care Conference
|
|
Mar 31, 05
|
| 09:01 ET |
Targacept to Present at the CIBC Biotechnology Conference
|
|
Mar 29, 05
|
| 09:04 ET |
Targacept Presents Promising Results at the 7th International Conference on Alzheimer's and Parkinson's Disease
|
|